US 11,833,310 B2
High flow nasal therapy system
Ronan MacLoughlin, Galway (IE); and Niall Smith, Central Scotland (GB)
Assigned to Stamford Devices Limited, Galway (IE)
Filed by Stamford Devices Limited, Galway (IE)
Filed on Jan. 23, 2020, as Appl. No. 16/750,507.
Application 16/750,507 is a continuation of application No. 15/301,318, granted, now 10,617,840, previously published as PCT/EP2015/057866, filed on Apr. 10, 2015.
Claims priority of application No. 14164468 (EP), filed on Apr. 11, 2014.
Prior Publication US 2020/0155788 A1, May 21, 2020
Int. Cl. A61M 16/08 (2006.01); A61M 16/06 (2006.01); A61M 16/16 (2006.01); A61M 16/20 (2006.01); A61M 11/00 (2006.01); A61M 15/08 (2006.01); A61M 16/14 (2006.01); A61M 16/10 (2006.01); A61M 16/00 (2006.01)
CPC A61M 16/16 (2013.01) [A61M 11/00 (2013.01); A61M 15/08 (2013.01); A61M 16/0666 (2013.01); A61M 16/0833 (2014.02); A61M 16/0866 (2014.02); A61M 16/0875 (2013.01); A61M 16/1095 (2014.02); A61M 16/14 (2013.01); A61M 16/202 (2014.02); A61M 2016/0018 (2013.01); A61M 2016/0027 (2013.01); A61M 2016/0033 (2013.01); A61M 2016/0036 (2013.01); A61M 2205/33 (2013.01); A61M 2205/3334 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A high flow nasal therapy system comprising:
a gas supply,
a humidifier,
a nebulizer,
a flow line having a first branch for delivery of aerosol and a second branch for delivery of non-aerosolized gas,
a nasal interface, and
a controller configured to control the system in real time to vary the aerosol delivery to the nasal interface on a temporal basis,
wherein the controller is configured to control delivery of inlet gas into the first branch and the second branch with a desired proportional split between the first branch and the second branch to provide aerosolized gas delivery during patient inhalation and delivery of non-aerosolized gas during patient exhalation.